Neogen Chemicals

Thane, India Founded: 1991 • Age: 35 yrs Listed
Specialty chemicals are manufactured for diverse applications worldwide.
Request Access
Report Incorrect Data
Page last updated

About Neogen Chemicals

Neogen Chemicals is a publicly listed company based in Thane (India) founded in 1991 by Haridas T Kanan. Specialty chemicals are manufactured for diverse applications worldwide. The company has 965 employees. Neogen Chemicals has completed 3 acquisitions, including Buli Chemicals India, CAPInnoVet and Paw Print Genetics. Its Indian entity Neogen Chemicals Limited reported revenue of ₹868 Cr. Neogen Chemicals offers products and services including Bromine Based Compounds, Grignard Reagents, Lithium Salts, and Advance Intermediates. Its focus areas include Chemicals and Materials, Diversified Chemicals and Speciality Chemicals.

Company details

Neogen Chemicals was established in 1991 in Thane, India, focusing on the production of specialty chemicals. Operations center on developing and supplying chemicals for industrial uses across sectors such as agrochemicals, pharmaceuticals, and electronics. The company is directed by founder Haridas T Kanan as Managing Director, alongside Harin Haridas Kanani in the same role. Activities are based primarily in India, with distribution extending to international markets.

  • Headquarters Thane, India
  • Employees 965
  • Founders Haridas T Kanan
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website neogenchem.com
  • Social LinkedIn
  • Legal Name Neogen Chemicals Ltd.
Operational Areas
Chemicals & Materials → Core & Diversified Chemicals
Key Metrics
  • Market Cap
    ₹6,795 Cr

    NEOGEN · NSE

  • Share Price
    ₹2,171.40

    -3.99% today

  • Revenue
    ₹862 Cr

    FY 2025-26 · +10.9% YoY

  • EBITDA
    ₹137 Cr

    Margin 15.9%

  • Net Profit
    ₹28.75 Cr

    FY 2025-26 · -33.6% YoY

  • P/E (TTM)
    191.9x

    P/B 4.3x

  • ROE
    3.6%

    ROCE 6.4%

  • Debt / Equity
    1.24

    Interest cover 68.4x

  • Employee Count
    965
  • Investments & Acquisitions
    Buli Chemicals India

    & 2 more

Products & Services of Neogen Chemicals

Neogen Chemicals offers a comprehensive portfolio of products and services, including Bromine Based Compounds, Grignard Reagents, Lithium Salts, and Advance Intermediates.

Bromine Based Compounds
Organic Chemicals

Compounds for chemical synthesis and industrial use.

Grignard Reagents
Inorganic Chemicals

Reagents used in organic synthesis processes.

Lithium Salts
Inorganic Chemicals

Salts for battery and chemical applications.

Advance Intermediates
Organic Chemicals

Intermediates for pharmaceutical and specialty uses.

Board of directors of Neogen Chemicals Limited (Neogen Chemicals)

Neogen Chemicals Limited is the primary company behind Neogen Chemicals. The board of Neogen Chemicals Limited currently have 8 directors; the longest-serving is Harin Haridas Kanani, appointed in 2013. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Harin Haridas Kanani
DIN 05136947
Managing Director15 Jul 201313 yrs 3 moNeogen Chemicals Limited
Shyamsunder Radheshyam Upadhyay
DIN 07274873
Whole-time director27 Jul 201511 yrs 3 moNeogen Chemicals Limited
Anurag Surana
DIN 00006665
Director15 May 20179 yrs 5 moNeogen Chemicals Limited
Avi Kersi Sabavala
DIN 08246256
Director06 Oct 20188 yrsNeogen Chemicals Limited
Ranjan Kumar Malik
DIN 08221989
Director06 Oct 20188 yrsNeogen Chemicals Limited
Rajeshkumar Babulal Shah
DIN 10729851
Director07 Aug 20242 yrs 2 moNeogen Chemicals Limited
Manoj Kumar Pati
DIN 06971840
Director26 Oct 20242 yrsNeogen Chemicals Limited
Triplicane Commandoor Narasimhan Saikrishnan
DIN 10498119
Director01 Oct 20251 yr 1 moNeogen Chemicals Limited

People of Neogen Chemicals

38 people are tracked at Neogen Chemicals (12 in leadership, 6 in board & advisors, 20 in team); the tracked headcount is 965.

NameRoleGroup
Haridas T Kanan
Founder & Managing DirectorLeadership
Harin Haridas Kanani
Managing DirectorLeadership
Ravi Bhensadadiya
General ManagerLeadership
Haridas Kanani
Chairman & Managing DirectorLeadership
Harin Kanani
Managing DirectorLeadership
Kirit Chauhan
Sr. Vice President - HRLeadership
Jitendra Kumar Sinha
Vice PresidentLeadership
Naresh Bolla
Assistant Vice PresidentLeadership
Nikhil Jain
General Manager FinanceLeadership
Dr Ankur Khant
Assistant General ManagerLeadership
Rupal Mehta
Sr. General Manager HRLeadership
Dr. Ashvin Kumar Upadhyay
Head Of Qc/adlLeadership
Hitesh Reshamwala
Independent DirectorBoard & advisors
Anurag Surana
Non-Executive DirectorBoard & advisors
Sanjay Mehta
Independent DirectorBoard & advisors
Ranjan Kumar Malik
Independent DirectorBoard & advisors
Avi Sabavala
Independent DirectorBoard & advisors
Shyamsunder Upadhyay
Whole Time DirectorBoard & advisors
Chintan Tanna
AGM Business DevelopmentTeam
Ankit Kayasth
Senior ExecutiveTeam

18 more people are available in the full profile.

Premium access

Complete people profiles for Neogen Chemicals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Neogen Chemicals

Neogen Chemicals is a publicly listed company on the NSE with ticker symbol NEOGEN in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date08 May 2019
  • Listed onBSE: 542665 · NSE: NEOGEN
  • Listed entityNeogen Chemicals Ltd.
  • Exchange sectorProcess industries
  • ISININE136S01016
  • Share price₹2,729.10 (+6.2% on the day) · 2026-10-14
  • Market capitalisation₹7,713 Cr
  • Price to earnings206.1
  • EPS (diluted, trailing year)₹13.24
  • Dividend yield0.04%
  • Volume (last session)574,128

Financials of Neogen Chemicals

Exchange-reported figures of Neogen Chemicals Limited, the listed company behind Neogen Chemicals (NSE: NEOGEN).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹862 Cr
+10.9% YoY
EBITDA
₹137 Cr
+12.3% YoY
Profit After Tax
₹28.75 Cr
-33.6% YoY
Net Worth
₹816 Cr
+3.4% YoY
Total Assets
₹2,229 Cr
+59.3% YoY
Total Debt
₹1,395 Cr
+133.8% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue862778691686487336306
Revenue growth+10.9%+12.6%+0.7%+40.8%+44.8%+9.9%-
EBITDA13712211011286.5964.3658.06
EBITDA margin+15.9%+15.7%+15.9%+16.3%+17.8%+19.1%+19.0%
Profit before tax41.0850.1652.7771.0357.0744.2141.10
Net profit28.7543.3235.6549.9744.6331.3328.65
Net profit margin+3.3%+5.6%+5.2%+7.3%+9.2%+9.3%+9.4%
EPS (₹)10.9013.2013.5120.0417.8913.4312.28
Balance sheet
Total assets2,2291,3991,182860676410306
Net worth816789760483439183156
Total debt1,395597409370229222137
Cash & bank4.954.9612.4920.7045.221.211.48
Net working capital732669528405299166188
Cash flow
Cash from operations(231)196(29.15)(30.35)1.4183.57(34.55)
Cash from investing(410)(317)(216)(94.46)(146)(135)(28.63)
Cash from financing64211323710018850.7362.64
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue250247220209187203201193
Revenue growth (YoY)+34.0%+21.6%+9.2%+7.9%+3.8%---
Other income4.061.012.201.981.230.641.140.84
EBITDA48.2343.9131.9029.9631.5122.3034.6434.51
EBITDA margin+19.3%+17.8%+14.5%+14.4%+16.9%+11.0%+17.2%+17.8%
Depreciation8.207.606.837.315.786.767.107.12
Interest20.8121.4721.5119.4812.6712.5013.4312.75
Profit before tax23.2815.855.765.1514.293.6815.2515.48
Tax6.174.462.071.784.031.275.244.52
Net profit17.1111.393.693.3710.262.4110.0110.96
EPS (₹)6.294.321.401.283.890.913.804.15
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue855774701686487336306
Revenue growth+10.6%+10.3%+2.2%+40.8%+44.8%+9.9%-
EBITDA15113411611286.5964.3658.06
EBITDA margin+17.7%+17.3%+16.6%+16.3%+17.8%+19.1%+19.0%
Profit before tax63.1366.3659.4671.1157.1644.3241.22
Net profit45.8357.9341.1350.0544.7231.4428.77
Net profit margin+5.4%+7.5%+5.9%+7.3%+9.2%+9.4%+9.4%
EPS (₹)17.8018.3515.5920.0717.9313.4812.33
Balance sheet
Total assets1,6031,2961,188861676410307
Net worth854809766483439183157
Total debt736474409370229222137
Cash & bank3.050.482.3020.7045.221.211.48
Net working capital719762639406299167189
Cash flow
Cash from operations(99.20)199(134)(30.35)1.2083.29(34.12)
Cash from investing(35.16)(188)(129)(94.46)(146)(134)(28.88)
Cash from financing137(12.14)22610018850.7362.46
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue252249216207185204200193
Revenue growth (YoY)+36.7%+22.0%+7.6%+7.0%+4.7%---
Other income7.903.874.264.373.312.652.052.24
Total expenses204203179172150176163157
EBITDA48.1645.3836.2634.9534.6827.6137.6536.49
EBITDA margin+19.1%+18.3%+16.8%+16.9%+18.8%+13.6%+18.8%+18.9%
Depreciation6.836.385.876.394.886.016.586.61
Interest23.1022.9522.8520.6014.0316.5013.0712.30
Profit before tax26.1319.9211.8012.3319.087.7520.0519.82
Tax6.695.263.033.024.852.565.644.96

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 31 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue250247220209187203201193
Revenue growth (YoY)+34.0%+21.6%+9.2%+7.9%+3.8%---
Other income4.061.012.201.981.230.641.140.84
EBITDA48.2343.9131.9029.9631.5122.3034.6434.51
EBITDA margin+19.3%+17.8%+14.5%+14.4%+16.9%+11.0%+17.2%+17.8%
Depreciation8.207.606.837.315.786.767.107.12
Interest20.8121.4721.5119.4812.6712.5013.4312.75
Profit before tax23.2815.855.765.1514.293.6815.2515.48
Tax6.174.462.071.784.031.275.244.52
Net profit17.1111.393.693.3710.262.4110.0110.96
EPS (₹)6.294.321.401.283.890.913.804.15
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue862778691686487336306
Revenue growth+10.9%+12.6%+0.7%+40.8%+44.8%+9.9%-
Other income6.424.217.654.551.250.520.21
Total expenses725655581575401272248
Employee cost12475.4962.0046.8231.5020.0717.25
EBITDA13712211011286.5964.3658.06
EBITDA margin+15.9%+15.7%+15.9%+16.3%+17.8%+19.1%+19.0%
Depreciation27.5227.7922.8716.2011.696.905.24
Interest75.1148.5042.0628.9419.0813.7711.93
Profit before tax41.0850.1652.7771.0357.0744.2141.10
Tax12.3315.3317.1221.0612.4412.8812.45
Net profit28.7543.3235.6549.9744.6331.3328.65
Net profit margin+3.3%+5.6%+5.2%+7.3%+9.2%+9.3%+9.4%
EPS (₹)10.9013.2013.5120.0417.8913.4312.28
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital26.3826.3826.3824.9424.9423.3323.33
Reserves & surplus790763734458414160133
Shareholders' funds (net worth)816789760483439183156
Minority interest0.000.000.000.000.000.000.00
Secured loans1,330566394362225216137
Unsecured loans65.2030.7015.397.304.025.740.00
Total debt1,395597409370229222137
Total liabilities2,2291,3991,182860676410306
Assets
Gross block568475561390313144120
Net block475404496347285127111
Capital work in progress85715610935.8410.621152.69
Investments0.450.450.4576.8181.730.750.60
Inventories568309382293195114130
Sundry debtors38020028217711078.5575.23
Cash & bank balances4.954.9612.4920.7045.221.211.48
Loans & advances43948610788.7262.3946.3724.47
Total current assets1,3931,000784580412240231
Total current liabilities66133125617411374.0243.11
Net working capital732669528405299166188
Total assets2,2291,3991,182860676410306
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash4.9612.5020.7045.221.211.482.02
Net cash from operating activities(231)196(29.15)(30.35)1.4183.57(34.55)
Net cash from investing activities(410)(317)(216)(94.46)(146)(135)(28.63)
Net cash from financing activities64211323710018850.7362.64
Net change in cash(0.03)(7.54)(8.20)(24.52)44.01(0.27)(0.54)
Closing cash4.954.9612.4920.7045.221.211.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.9%+12.6%+0.7%+40.8%+44.8%+9.9%-
EBITDA growth+12.3%+11.1%-1.4%+28.9%+34.5%+10.9%-
PBT growth-18.1%-5.0%-25.7%+24.5%+29.1%+7.6%+40.5%
Net income growth-33.6%+21.5%-28.7%+12.0%+42.5%+9.4%-
Revenue CAGR (3Y)+7.9%+16.9%+27.1%+30.9%+26.8%+27.8%+40.6%
EBITDA CAGR (3Y)+7.1%+12.2%+19.6%+24.3%+25.9%+30.4%+42.7%
Profitability & leverage
Net income margin+3.3%+4.5%+5.2%+7.3%+9.2%+9.3%+9.4%
Return on capital employed+6.4%+8.7%+9.3%+13.0%+14.0%+16.2%+21.2%
Return on net worth+3.6%+5.6%+5.7%+10.8%+14.3%+18.5%+25.3%
Debt / equity1.240.650.630.650.721.061.03
Long-term debt / equity0.660.210.220.280.390.440.29
Interest cover68.4251.3548.2530.3325.4723.9622.59
Efficiency & per share
Fixed asset turnover1.651.501.451.952.133.043.34
Inventory turnover1.962.252.052.813.163.293.44
Debtors turnover2.973.233.014.785.185.215.12
EPS (₹)10.9013.2013.5120.0417.8913.4312.28
Dividend per share (₹)2.001.002.003.002.752.252.00
Book value per share (₹)309.43299.24288.21193.47176.1278.4466.96
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue252249216207185204200193
Revenue growth (YoY)+36.7%+22.0%+7.6%+7.0%+4.7%---
Other income7.903.874.264.373.312.652.052.24
Total expenses204203179172150176163157
EBITDA48.1645.3836.2634.9534.6827.6137.6536.49
EBITDA margin+19.1%+18.3%+16.8%+16.9%+18.8%+13.6%+18.8%+18.9%
Depreciation6.836.385.876.394.886.016.586.61
Interest23.1022.9522.8520.6014.0316.5013.0712.30
Profit before tax26.1319.9211.8012.3319.087.7520.0519.82
Tax6.695.263.033.024.852.565.644.96
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue855774701686487336306
Revenue growth+10.6%+10.3%+2.2%+40.8%+44.8%+9.9%-
Other income15.829.768.084.631.340.630.33
Total expenses704640585575401272248
Employee cost77.7258.2957.3246.8231.5020.0717.25
EBITDA15113411611286.5964.3658.06
EBITDA margin+17.7%+17.3%+16.6%+16.3%+17.8%+19.1%+19.0%
Depreciation23.5325.5922.8216.2011.696.905.24
Interest80.4251.3842.0028.9419.0813.7711.93
Profit before tax63.1366.3659.4671.1157.1644.3241.22
Tax16.1717.9518.3321.0612.4412.8812.45
Net profit45.8357.9341.1350.0544.7231.4428.77
Net profit margin+5.4%+7.5%+5.9%+7.3%+9.2%+9.4%+9.4%
EPS (₹)17.8018.3515.5920.0717.9313.4812.33
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital26.3826.3826.3824.9424.9423.3323.33
Reserves & surplus827782740458414160133
Shareholders' funds (net worth)854809766483439183157
Secured loans671444394362225216137
Unsecured loans64.2630.7015.407.304.025.740.00
Total debt736474409370229222137
Total liabilities1,6031,2961,188861676410307
Assets
Gross block384299428390313144119
Net block294228361347285127111
Capital work in progress16127.5356.1035.8410.621152.69
Investments3071935.4576.5181.210.450.45
Inventories552306382293195114130
Sundry debtors35719928217711078.5575.23
Cash & bank balances3.050.482.3020.7045.221.211.48
Loans & advances36056116589.1262.9946.7825.11
Total current assets1,2711,066832580412241232
Total current liabilities55330419317411374.0243.11
Net working capital719762639406299167189
Total assets1,6031,2961,188861676410307
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.482.3038.9945.221.211.482.02
Net cash from operating activities(99.20)199(134)(30.35)1.2083.29(34.12)
Net cash from investing activities(35.16)(188)(129)(94.46)(146)(134)(28.88)
Net cash from financing activities137(12.14)22610018850.7362.46
Net change in cash2.56(1.82)(36.69)(24.52)44.01(0.27)(0.54)
Closing cash3.050.482.3020.7045.221.211.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.6%+10.3%+2.2%+40.8%+44.8%+9.9%-
EBITDA growth+13.2%+15.0%+4.1%+28.9%+34.5%+10.9%-
PBT growth-4.9%+11.6%-16.4%+24.4%+29.0%+7.5%+40.4%
Net income growth-20.9%+40.9%-17.8%+11.9%+42.2%+9.3%-
Revenue CAGR (3Y)+7.6%+16.7%+27.8%+30.9%+26.8%+27.8%+40.6%
EBITDA CAGR (3Y)+10.7%+15.5%+21.8%+24.3%+25.9%+30.4%+42.7%
Profitability & leverage
Net income margin+5.5%+6.3%+5.9%+7.3%+9.2%+9.4%+9.4%
Return on capital employed+9.9%+10.6%+9.9%+13.0%+14.0%+16.2%+21.2%
Return on net worth+5.7%+7.4%+6.6%+10.9%+14.4%+18.5%+25.3%
Debt / equity0.730.560.620.650.721.061.03
Long-term debt / equity0.210.130.220.280.390.440.29
Interest cover62.9647.5844.9830.3325.4723.9622.59
Efficiency & per share
Fixed asset turnover2.502.131.721.952.133.053.37
Inventory turnover1.992.252.082.813.163.293.44
Debtors turnover3.083.213.054.785.185.215.12
EPS (₹)17.8018.3515.5920.0717.9313.4812.33
Dividend per share (₹)2.001.002.003.002.752.252.00
Book value per share (₹)323.62306.61290.41193.51176.1578.4967.17

Investments & Acquisitions by Neogen Chemicals

Neogen Chemicals has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Buli Chemicals India, CAPInnoVet and Paw Print Genetics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Buli Chemicals India
Speciality chemicals and related products are manufactured.
bulichemicalsindia.tcc.modeMumbai, India2018Mar 2023••••
Paw Print Genetics
Genetic testing for canines is provided to owners and breeders.
pawprintgenetics.comSpokane, United States2012Dec 2021••••
CAPInnoVet
Pet health products are manufactured by CAPInnoVet in Atlanta.
capinnovet.comAtlanta, United States2014Sep 2021••••
Premium access

Complete acquisition details for Neogen Chemicals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Neogen Chemicals

5 dated milestones of Neogen Chemicals across 32 years, from founding to its latest funding, stage changes and deals.

  1. Founded Neogen Chemicals is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires CAPInnoVet.
  4. Acquisition Acquires Paw Print Genetics.
  5. Acquisition Acquires Buli Chemicals India.

Web traffic of Neogen Chemicals

The website of Neogen Chemicals (neogenchem.com) receives about 6.5K visits a month.

  • Monthly visits
    6.5K

    ▲ 67.4% vs previous month

Similar websites

Websites whose visitors overlap most with Neogen Chemicals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Indian Chemical News
indianchemicalnews.com
100%
#555,272View details
Yasho Industries
yashoindustries.com
97%
4.3K#4,362,536View details
Speciality Chemicals Magazine
specchemonline.com
97%
#1,875,513View details
Allround Engineering
abscomaterials.com
97%
#12,344,100View details
dge-europe.com
dge-europe.com
97%
#5,682,776–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 6 similar websites and full traffic analytics for Neogen Chemicals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as Neogen Chemicals (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
DFPCL
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Scimplify
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 2.13 M
Himadri Chemicals and Industries
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 496.46 M2,480
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Neogen Chemicals

Neogen Chemicals: Morita Investment To Invest ₹76.80 Crore In Neogen Morita New Materials, Acquire 9.09% Stake
Exchange Update • 1 month ago
Neogen Chemicals targets ₹1,250-1,350 crore FY27 revenue as battery business ramps up - CNBC TV18
CNBCTV18 • 1 month ago
Government Plans New Program to Enhance Lithium and Nickel Processing, Reports Mines Secretary Keshav Chandra.
Exchange Update • 1 month ago
Neogen Chemicals' maiden QIP oversubscribed 6.5x, raises ₹600 crore
Hello Entrepreneurs • 1 month ago
Neogen Chemicals: Raises ₹600 Crore Through QIP, Shares Allotted At ₹2,255 Each With 6.5X Oversubscription
Exchange Update • 1 month ago
Abu Dhabi Investment Authority among others issued shares in Neogen Chemicals' ₹600 crore QIP - CNBC TV18
CNBCTV18 • 1 month ago
Neogen Chemicals: Co raises ₹600cr through QIP at ₹2,255/share, allotting 26.61 lakh equity shares to eligible QIBs.
Exchange Update • 1 month ago
Stocks to Watch Today (Sep 11): Vodafone Idea, Neogen Chemicals, KIMS, Granules India and more
ZEE Business • 1 month ago
₹600 cr Neogen QIP: Floor price, key dates, discount option, approvals and other details | Stock Market News
mint • 1 month ago
Neogen Chemicals launches QIP issue to raise funds amounting to Rs 600 crore | Capital Market News - Business Standard
Business Standard • 1 month ago
Premium access

Complete news archive for Neogen Chemicals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neogen Chemicals

Neogen Chemicals was founded in 1991.

Neogen Chemicals is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.

Neogen Chemicals has 965 employees.

The primary company behind Neogen Chemicals, Neogen Chemicals Limited, reported revenue of ₹868 Cr for FY 2026, up 11% year on year.

Neogen Chemicals was established in 1991 in Thane, India, focusing on the production of specialty chemicals. Operations center on developing and supplying chemicals for industrial uses across sectors such as agrochemicals, pharmaceuticals, and electronics. The company is directed by founder Haridas T Kanan as Managing Director, alongside Harin Haridas Kanani in the same role. Activities are based primarily in India, with distribution extending to international markets.

Neogen Chemicals offers Bromine Based Compounds, Grignard Reagents, Lithium Salts, and Advance Intermediates.

Yes, Neogen Chemicals is publicly traded on NSE under the ticker symbol NEOGEN.

Neogen Chemicals has made 3 acquisitions, including Buli Chemicals India, CAPInnoVet, and Paw Print Genetics.

Neogen Chemicals operates through Neogen Chemicals Limited.

The legal entities of Neogen Chemicals currently have 10 directors, including Shyamsunder Radheshyam Upadhyay, Unnati Rajesh Kanani, Harin Haridas Kanani and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available